Article | July 21, 2023

Data-Driven Adaptive Trials: Enhancing Safety, Accelerating Progress, And Boosting Economics Through Enhanced Insights

By Chris Driver, IQVIA

GettyImages-1344606074 data insights

The use of "big data" in clinical trials has been a topic of discussion for over a decade. Trial sponsors face the challenge of handling vast and diverse data from multiple trial sites. With the right technology, sponsors can integrate extensive statistical information into adaptive trials, enabling real-time interim analysis.

Advancements in data-driven technology have empowered sponsors to make informed decisions about trial funding, treatment arm modifications, and other essential changes during the study. Despite the increasing manageability of vast data, extracting meaningful insights remains complex. However, clinical technology providers, particularly those offering interactive response technology (IRT), are leading the way in helping sponsors overcome these challenges.

By offering guidance on optimizing ROI from extensive data collections and various endpoints in clinical studies, learn how IRT technology can enhance the data-driven approach for sponsors.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Supply Leader? Subscribe today.

Subscribe to Clinical Supply Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Clinical Supply Leader